Does Rallies show Form 4 insider transactions for UPXI?

Yes. Rallies tracks UPXI insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is UPXI research on Rallies investment advice?

No. Rallies provides research, data, and educational context for UPXI. It does not provide personalized investment advice.

UPXI (Upexi, Inc. Common Stock) Stock Analysis - Insider Trades

Upexi, Inc. Common Stock (UPXI) is a publicly traded Communication Services sector company. As of May 20, 2026, UPXI trades at $1.40 with a market cap of $92.75M and a P/E ratio of -0.80. UPXI moved +8.91% today. Year to date, UPXI is -32.46%; over the trailing twelve months it is -86.62%. Its 52-week range spans $0.54 to $22.57. Analyst consensus is buy with an average price target of $2.00. Rallies surfaces UPXI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading UPXI stock inside the company?

Recent UPXI insider activity includes MARSHALL ALLAN bought 50.00K, MARSHALL ALLAN bought 50.00K, MARSHALL ALLAN bought 100.00K, Salkind Gene bought 50.00K, and Salkind Gene bought 100.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

UPXI Key Metrics

Key financial metrics for UPXI
Metric	Value
Price	$1.40
Market Cap	$92.75M
P/E Ratio	-0.80
EPS	$-1.73
Dividend Yield	0.00%
52-Week High	$22.57
52-Week Low	$0.54
Volume	2.66M
Avg Volume	0
Revenue (TTM)	$15.81M
Net Income	$-13.68M
Gross Margin	68.74%

Recent UPXI Insider Trades

MARSHALL ALLAN bought 50.00K (~$90.00K) on Dec 23, 2025.
MARSHALL ALLAN bought 50.00K (~$103.50K) on Dec 16, 2025.
MARSHALL ALLAN bought 100.00K (~$207.00K) on Dec 15, 2025.
Salkind Gene bought 50.00K (~$127.50K) on Nov 20, 2025.
Salkind Gene bought 100.00K (~$265.00K) on Nov 17, 2025.

Latest UPXI News

SOL Strategies Buys Darklake Labs for $1.2M and Eyes $18M Houdini Deal — May 20, 2026
Upexi Boosts Solana Holdings 9% to 2M+ SOL, Reports Q3 Loss of $109M — May 12, 2026
Upexi Repurchases 2.9M Shares, Leaves $47.2M Buyback Capacity — May 6, 2026
Upexi Posts $8.1M Q2 Revenue, Gross Profit Up 126%, Launches $50M Buyback — Feb 10, 2026

UPXI Analyst Consensus

1 analysts cover UPXI: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $2.00.

Common questions about UPXI

Who is trading UPXI stock inside the company?: Recent UPXI insider activity includes MARSHALL ALLAN bought 50.00K, MARSHALL ALLAN bought 50.00K, MARSHALL ALLAN bought 100.00K, Salkind Gene bought 50.00K, and Salkind Gene bought 100.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for UPXI?: Yes. Rallies tracks UPXI insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is UPXI research on Rallies investment advice?: No. Rallies provides research, data, and educational context for UPXI. It does not provide personalized investment advice.